Acousys Biodevices Inc
Acousys Biodevices Inc., based in Ann Arbor, MI, is at the forefront of cancer diagnostics, specializing in the detection of circulating tumor cells (CTCs) to predict cancer recurrence or metastasis. Their innovative CTC detection system has shown the ability to identify circulating melanoma cells in patients with stage I-III malignant melanoma up to eight years before traditional tumor detection methods.
Founded by Dr. John Viator, Ph.D., Acousys is recognized for its extraordinary sensitivity in detecting and capturing rare CTCs, which can subsequently be analyzed for drug sensitivity. This technology not only facilitates early monitoring of cancer patients but also aids in personalizing treatment strategies for better health outcomes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.